Loading clinical trials...

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 4NCT00661206

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

The purpose of this study is to determine whether a 6 month duration of clopidogrel therapy after DES implantation is not inferior to that of a 12 month therapy.

Lead sponsor: Deutsches Herzzentrum Muenchen•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

RECRUITINGNA

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more

RECRUITING

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease

RECRUITING

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

NCT05770349 · Heart Failure, Coronary Artery Disease

RECRUITINGNA

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT06779630 · Coronary Artery Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 9, 2014Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment4,005

Start dateSep 2008

Last updatedOct 9, 2014

Condition

Coronary Artery Disease

Locations shown

University of Florida, Health Science Center - Jacksonville

Jacksonville, Florida

Spitali Gjerman

Tirana

Krankenanstalt Rudolfstiftung

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 9, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Trial snapshot

Condition

Locations shown

For caregivers